Jindian Tangyi: A Compassionate Diabetes Management App Bridging Online and Offline Care

Amid the overarching trend of mobile internet disrupting traditional industries, the mobile health sector experienced explosive growth between 2014 and 2015. According to incomplete statistics from third-party agencies, more than 2,000 various mobile health applications were launched across major app markets. In the niche field of diabetes management, there were over one hundred apps with “Tang” (sugar) in their names available on major app stores, with more than ten achieving significant download volumes and user engagement, truly ushering in an era of “fierce competition among a hundred sugar-focused apps.” This raises the question: given such intense industry competition, why did Jin Dian Tang Yi choose to enter this crowded and complex market at this particular time?

Yuan Ye stated that if diabetes is not effectively managed and controlled, it can ultimately progress to serious complications such as diabetic retinopathy, nephropathy, and foot disease, which may even be life-threatening. In daily diabetes management, while hyperglycemia must be lowered, many people may not realize that hypoglycemia caused by improper medication use is even more dangerous. Medication management for diabetic patients involves multifaceted knowledge, including the selection of drug types (with 20–30 commonly used antidiabetic agents available), timing of administration, and dosage. The regimen becomes even more complex when insulin therapy is involved. Additionally, professional expertise is required in other areas such as dietary and exercise management.

In developed countries in Europe and the United States, most people have their own private physicians, making access to such services effortless; patients can simply call their private doctors when issues arise. In contrast, China currently has over 100 million diabetic patients but only 20,000–30,000 diabetes specialists. On average, each physician must manage 5,000 to 10,000 patients. Providing high-quality care to every patient under these circumstances is an impossible task, even if doctors were to forgo eating, drinking, and sleeping entirely.

Professional Expertise onPatients with Common DiabetesLet's discussDifficult to fully master, and given the individual and clinical variations among diabetes patients, big data and the internet alone cannot resolve all issues. Coupled with limited real-world medical resources and numerous pain points existing between doctors and patients as well as across the industry, it is particularly crucial to identify effective solutions for these various challenges.“This is also the original intention behind creating Golden Classic Diabetes Care. Only by doing our work properly can we build a meaningful career. We are not omnipotent, nor do we blindly follow popular opinion. We need to calm down and pragmatically accomplish tangible, substantive tasks to truly make a difference in diabetes management,” said Yuan Ye.

“Annual rings are not mere traces of passing years, but rather a testament to accumulated strength released after a period of sedimentation. They represent the courage and perseverance that underpin confidence. Of course, every member of our team holds fast to their original dreams. ‘When you do the right thing, you fear no hardship,’ says Yuan Ye.”

For 15 years, the Jindian brand has been deeply engaged in the field of diabetes care. Acutely aware of the distress caused by the lack of private physician services for patients with diabetes, it has drawn upon advanced diabetes management experiences from countries and regions such as the United States, Japan, and Taiwan, while integrating these insights with China’s specific national conditions,We have established an effective diabetes management model, which Jingdian Ren refers to as "C&S All-Time Care."UpcomingCare（Treatment) and Service (服务)Integrated into a unified system, establishing an integrated diabetes management and service system through comprehensive, end-to-end, and round-the-clock management.

“C&S Full-Time Care” is based onProfessionally TrainedDiabetesChronic Disease ManagementTeam-centered, adopting the “1+5+1+1” model (1 physician + 5 specialized diabetes management nurses + 1 dietitian + 1 health manager)Architecture, with support from endocrinology experts and specialized hospitals, ensuring that care and service are infused into every moment and that chronic disease management is ingrained in the team’s core values, so as toImplementationTiered Diagnosis and Treatment, Personalized Solutions,Regular Treatment and Follow-upFollow-up、Post-Recovery Care and Out-of-Hospital Managementa complete management and service system. This system has served thousands of patients and gained widespread recognition. The launch of the Jindian Tangyi APP merely extends these service capabilities online, providing more patients with convenient access to medical care and supporting self-management across time and space. Therefore, for Jindian, developing a diabetes management APP with a human touch was a natural progression.

The True Warmth of Jindian: Genuinely Meeting Patients’ Actual Needs. Seamless Integration Across In-Hospital and Out-of-Hospital Settings, as Well as Online and Offline Channels.。

Regarding the widespread challenge of identifying viable business models in the mobile health industry, Yuan Ye remains composed. “We operate five specialized diabetes hospitals and have been profitable from the outset. Our online and offline operations are fully integrated, with online services driving profitability in our offline medical practices. We are a typical example of ‘Internet Plus,’ where the internet has provided the wings for our company’s second phase of rapid growth.”Yuan Ye is equally unperturbed about financing and going public. “We have specific criteria for institutional investors. First, they must share our core values. Second, beyond capital, we prefer investors who possess resources across the upstream and downstream segments of the healthcare industry. This would enable us to jointly integrate the chronic diabetes care value chain, extending our ecosystem beyond our own closed-loop diabetes management system.” Yuan Ye also revealed that the company’s IPO plans are proceeding steadily.

In Yuan Ye’s view, various apps are merely the form, while the essence of healthcare is the spirit. Mobile health must ultimately return to the core of medicine: treating diseases and saving lives. Finally, Yuan Ye confidently stated that he believes Jindian is currently the only company in China bold enough to present a business model capable of achieving closed-loop management for diabetes.

(The content of this article was provided by Yang Hui.)